Table 1 Baseline and oncologic characteristics of the included patients
|  | SEMS group (n = 35) | Emergency group (n = 72) | P |
|---|---|---|---|
Baseline characteristics | |||
 Age, y |  |  | 0.144 |
  Median | 66 | 67 |  |
  Range | 24–92 | 23–94 |  |
 Sex, no. (%) |  |  | 0.131 |
  Male | 21 (60.0%) | 32 (44.4%) |  |
  Female | 14 (40.0%) | 40 (55.6%) |  |
 Comorbidity, no. (%) |  |  |  |
  Hypertension | 10 (28.6%) | 14 (19.4%) | 0.288 |
  Diabetes mellitus | 5 (14.3%) | 11 (15.3%) | 0.893 |
  Cardiovascular disease | 3 (8.6%) | 6 (8.3%) | 1.000 |
  Pulmonary disease | 2 (5.7%) | 2 (2.8%) | 0.596 |
  Neurologic disease | 1 (2.9%) | 2 (2.8%) | 1.000 |
  Other malignancy | 2 (5.7%) | 3 (4.2%) | 0.661 |
  Renal disease | 0 (0%) | 1 (1.4%) | 1.000 |
Oncologic characteristics | |||
 Tumor size, mean (± SD), cm | 7.71 ± 3.70 | 5.85 ± 2.58 | 0.216 |
 Tumor location, no. (%) |  |  | 0.022 |
  Cecum | 0 (0%) | 11 (15.3%) |  |
  Ascending colon | 12 (34.3%) | 26 (36.1%) |  |
  Hepatic flexure | 7 (30.0%) | 17 (23.6%) |  |
  Transverse colon | 16 (45.7%) | 18 (25.0%) |  |
 Pathology, no. (%) |  |  | 0.893 |
  Adenocarcinoma | 30 (85.7%) | 61 (84.7%) |  |
  Well differentiated | 2 (5.7%) | 3 (4.2%) |  |
  Moderately differentiated | 26 (74.3%) | 54 (75.0%) |  |
 Poorly differentiated | 2 (5.7%) | 4 (5.5%) |  |
 Mucinous | 5 (14.3%) | 11 (15.3%) |  |
Lymphovascular involvement, no. (%) | Â | Â | Â |
 Yes | 13 (37.1%) | 17 (23.6%) | 0.144 |
 No | 22 (62.9%) | 55 (76.4%) |  |
 pTNM stage |  |  | 0.240 |
  II | 16 (45.7%) | 31 (43.1%) |  |
  III | 12 (34.3%) | 34 (47.2%) |  |
  IV | 7 (20.0%) | 7 (9.7%) |  |